Prävalenz des Plasmafaktormangels in der Wiener Bevölkerung-Reference-Cited by-同舟云学术

Prävalenz des Plasmafaktormangels in der Wiener Bevölkerung

Published:1988-09 Issue:17 Volume:66 Page:779-783
ISSN:0023-2173
Container-title:Klinische Wochenschrift
language:de
Short-container-title:Klin Wochenschr

Author:

Sinzinger H.,Flores J.,Rauscha F.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01726578.pdf

Reference31 articles.

1. Arnout J, Kienast J, Deckmyn H, Vermylen J (1987) Prostacyclin stimulatory activity of reducing cofactors in human plasma filtrate. A potential role for uric acid. Agents Actions (in press)

2. Bukowski RM, King JW, Hewlett JS (1977) Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 50:413–417

3. Chamone DA, Proesmans WC, Mounens LA, Binda Ki Muaka P, Vermylen JG (1982) Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome. Int J Pediatr Nephrol 3:13–16

4. Deckmyn H, Gresele P, Arnout J, Todisco A, Vermylen JG (1984) Prolonging prostacyclin production by nafazatrom and dipyridamole. Lancet II:410–412

5. Deckmyn H, Zoja C, Arnout J, Todisco A, Vanden Bulcke F, D'Hondt L, Hendrickx N, Gresele P, Vermylen JG (1985) Partial isolation and function of the prostacyclin regulating plasma factor. Clin Science 69:383–393

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is a(n inborn) deficiency of prostacyclin synthesis stimulating plasma factor associated with increased lipoprotein(a)?;Prostaglandins, Leukotrienes and Essential Fatty Acids;1996-11

2. Eicosanoids in atherosclerosis;Experimental pathology;1991-01

3. Defects in the prostaglandin-system — Heredity, prevalence and vascular risk analysis;Prostaglandins, Leukotrienes and Essential Fatty Acids;1990-07